MAFM
NVO

Mid Atlantic Financial Management’s Novo Nordisk NVO Stock Holding History

Mid Atlantic Financial Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-400
Closed -$1K – 950
2021
Q2 		$1K Buy
+400
New +$15.5K ﹤0.01% 924

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mid Atlantic Financial Management's NVO Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its Novo Nordisk (NVO) stake by 4.4% in Q3 2021, selling an estimated $39.4K and leaving 17,726 shares worth $851K. The position accounts for 0.06% of the portfolio, ranked #296.

Mid Atlantic Financial Management first reported a position in NVO in Q4 2018 and has held it in 12 quarters since. 805 funds tracked by Wall St. Rank hold NVO as of Q3 2021.

  • Mid Atlantic Financial Management held 17,726 shares of Novo Nordisk worth $851K as of Q3 2021.
  • Mid Atlantic Financial Management sold 816 Novo Nordisk shares in Q3 2021, an estimated $39.4K.
  • Novo Nordisk made up 0.06% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #296 holding.
  • Mid Atlantic Financial Management first reported a position in Novo Nordisk in Q4 2018 and has held it in 12 quarters since.
  • 805 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.